Eurofins expands to China to strengthen local expertise

Eurofins Healthcare Assurance, a global leader in safety and quality assurance services, is excited to announce the opening of its new establishment in China. This move follows the successful launch of a unit in India earlier this year, reinforcing the company’s strong commitment to providing more comprehensive services across multiple sectors, including pharmaceuticals, healthcare, cosmetics, and food supplements.

China, as a major player in the global pharmaceutical industry, holds a central position in the supply of raw materials and ingredients. According to market research from Statista, China accounted for 44 percent of the world’s active pharmaceutical ingredients (APIs) and excipients exports in 2023. Given this, Eurofins Healthcare Assurance recognises the importance of local operations in maintaining close proximity to key markets, better understanding customer needs, and staying aligned with industry trends.

Building on over 20 years of expertise, Eurofins Healthcare Assurance is determined to offer local customers in China enhanced support, all while maintaining its world-renowned level of quality and innovation. The company’s dedicated team, which includes experts from Europe, the USA, India, and China, is focused on delivering a broad array of services that meet the unique demands of each market.

Pharmaceutical, healthcare, cosmetic, and food supplement businesses can rely on Eurofins Healthcare Assurance to help them navigate strict international and national regulatory requirements, ensuring that their products meet the highest standards of safety and quality. The company remains dedicated to expanding its reach and continually improving its offerings to provide an even better experience for customers worldwide.

To learn more about Eurofins Healthcare Assurance’s services, please visit Eurofins Healthcare Assurance.